Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000411709 | SCV000486386 | likely pathogenic | Neuronal ceroid lipofuscinosis 1 | 2016-05-23 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000411709 | SCV004204168 | likely pathogenic | Neuronal ceroid lipofuscinosis 1 | 2023-11-08 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000411709 | SCV004267494 | pathogenic | Neuronal ceroid lipofuscinosis 1 | 2023-09-26 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asn218Lysfs*16) in the PPT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PPT1 are known to be pathogenic (PMID: 10679943, 21990111). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PPT1-related conditions. ClinVar contains an entry for this variant (Variation ID: 370947). For these reasons, this variant has been classified as Pathogenic. |